Unknown

Dataset Information

0

6-C-(E-phenylethenyl)-naringenin suppresses colorectal cancer growth by inhibiting cyclooxygenase-1.


ABSTRACT: Recent clinical trials raised concerns regarding the cardiovascular toxicity of selective cyclooxygenase-2 (COX-2) inhibitors and cyclooxygenase-1 (COX-1) is now being reconsidered as a target for chemoprevention. Our aims were to determine whether selective COX-1 inhibition could delay or prevent cancer development and also clarify the underlying mechanisms. Data clearly showed that COX-1 was required for maintenance of malignant characteristics of colon cancer cells or tumor promoter-induced transformation of preneoplastic cells. We also successfully applied a ligand-docking computational method to identify a novel selective COX-1 inhibitor, 6-C-(E-phenylethenyl)-naringenin (designated herein as 6CEPN). 6CEPN could bind to COX-1 and specifically inhibited its activity both in vitro and ex vivo. In colorectal cancer cells, it potently suppressed anchorage-independent growth by inhibiting COX-1 activity. 6CEPN also effectively suppressed tumor growth in a 28-day colon cancer xenograft model without any obvious systemic toxicity. Taken together, COX-1 plays a critical role in human colorectal carcinogenesis, and this specific COX-1 inhibitor merits further investigation as a potential preventive agent against colorectal cancer.

SUBMITTER: Li H 

PROVIDER: S-EPMC3947334 | biostudies-literature | 2014 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

6-C-(E-phenylethenyl)-naringenin suppresses colorectal cancer growth by inhibiting cyclooxygenase-1.

Li Haitao H   Zhu Feng F   Chen Hanyong H   Cheng Ka Wing KW   Zykova Tatyana T   Oi Naomi N   Lubet Ronald A RA   Bode Ann M AM   Wang Mingfu M   Dong Zigang Z  

Cancer research 20131112 1


Recent clinical trials raised concerns regarding the cardiovascular toxicity of selective cyclooxygenase-2 (COX-2) inhibitors and cyclooxygenase-1 (COX-1) is now being reconsidered as a target for chemoprevention. Our aims were to determine whether selective COX-1 inhibition could delay or prevent cancer development and also clarify the underlying mechanisms. Data clearly showed that COX-1 was required for maintenance of malignant characteristics of colon cancer cells or tumor promoter-induced t  ...[more]

Similar Datasets

| S-EPMC3734178 | biostudies-literature
| S-EPMC7736850 | biostudies-literature
| S-EPMC8125196 | biostudies-literature
| S-EPMC5731927 | biostudies-literature
| S-EPMC4123095 | biostudies-literature
| S-EPMC6001674 | biostudies-literature
| S-EPMC7205901 | biostudies-literature
| S-EPMC7840714 | biostudies-literature
| S-EPMC6779829 | biostudies-literature
| S-EPMC6603418 | biostudies-literature